Neuromuscular Blocking Agents

All categories
DBCAT000511Therapeutic category

Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). A DrugBank category of 24 drugs. 21 of them are approved.

Part of
Neuromuscular Agents
Also known as
Agents, Neuromuscular Blocking · Blockers, Neuromuscular · Blocking Agents, Neuromuscular · Neuromuscular Blockers · Neuromuscular-Blocking Agents
Drugs

What you can answer from here — as of July 05, 2018

24DrugsEach linked to its full drug card
Listed above
20Drug targetsEvery drug–target pair in the class, with bond type
Sign in
987Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
9Routes of administrationHow the drugs in this class are given
Sign in
2SubcategoriesNarrower classes within this one
Sign in

Which targets do Neuromuscular Blocking Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In